在神经眼科疾病中,基于细胞外囊的治疗方法
Hamed Massoumi1,2, Sohil Amin1, Mohammad Soleimani1
1Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL 60612, USA.
International journal of molecular sciences
|May 27, 2023
概括
细胞外囊泡 (EVs) 通过输送治疗分子和促进神经再生,显示出治疗眼睛疾病的前景. 需要进一步的研究,以克服眼科疾病临床使用的挑战.
科学领域:
- 眼科医生 眼科 眼科
- 再生医学是一种再生医学.
- 生物技术是生物技术.
背景情况:
- 细胞外囊泡 (EVs) 正在成为各种病理的强有力的治疗剂.
- 它们提供生物活性分子的能力使得它们非常适合治疗眼部疾病.
- 从介质细胞 stromal 细胞 (MSCs) 衍生出的 EVs 在神经再生方面特别有前途.
研究的目的:
- 审查EVs在眼部疾病中的治疗潜力.
- 为了突出它们在眼睛内神经再生中的作用.
- 讨论临床翻译的挑战和未来方向.
主要方法:
- 对针对眼部疾病的基于EV的疗法进行的临床前和临床研究的审查.
- 分析电动汽车货物,隔离和表征技术.
- 检查作用机制,包括细胞存活,抗炎症和组织再生.
主要成果:
- 在角膜损伤,糖尿病视网膜病变,视神经损伤和玻璃眼病模型中,EVs表现出治疗效果.
- 来自MSC的EV促进了轴突再生和在视神经受伤时的功能恢复.
- 电动汽车可以提供神经营养因子并调节视网膜炎症.
结论:
- 电动眼镜在一系列眼科疾病中具有显著的治疗潜力,特别是神经再生.
- 临床翻译的挑战需要进一步的研究和开发.
- 对EV隔离,表征和输送的持续研究对于推进基于EV的眼科治疗至关重要.
相关概念视频
Drug Delivery: Miscellaneous Routes
409
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
409
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
354
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
354


